Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Determining the best age to start retirement planning can set you on a path to financial success. Learn why starting early matters.
17,973 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
When oil climbs past $100, some stocks tend to move higher more often than not. This guide breaks down five names tha...
Two iconic automakers face two different futures. This analysis breaks down why Ford may offer a stronger industrial ...
As regulators settle the status of digital assets and major networks scale, XRP and Solana remain top bets for a long...
Bitcoin dipped over the weekend, but traders rotated into infrastructure-focused bets as the Bitcoin Hyper presale su...
OpenAI’s IPO-style risk disclosure confirms Microsoft’s central role in its operations, signaling potential leverage ...
Bittensor's $52 million annual subsidy governs the network's top subnets, creating an 'income desert' that could unra...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
After years of outsized gains, the magnificent seven faces a pullback. This guide explains how to evaluate the dip, p...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...
Zillow reports a strong start to 2026 with rising revenue and a bold pre-marketing push. The Zillow Preview program d...